Among persons with and without HIV, prescribed opioids, especially higher-dose and immunosuppressive opioids, are associated with increased community-acquired pneumonia (CAP) risk, a recent study found. The nested case-control study included 4,246 cases and 21,146 controls (n=25,392) participants living with and without HIV who received care in Veterans Health Administration (VA) medical centers across the US. The primary outcome was CAP requiring hospitalization. Researchers found:
- Prescribed opioids were independently associated with CAP in those living with and without HIV.
- The risk for CAP increased with higher opioid doses and opioids with known immunosuppressive properties.
- In stratified analyses, CAP risk was consistently greater among people living with HIV with current prescribed opioids.
Edelman EJ, Gordon KS, Crothers K, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. [Published online ahead of print January 7, 2019]. JAMA Intern Med. doi:10.1001/jamainternmed.2018.6101.
This Week's Must Reads
AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al
Coffee Consumption & Plasma Biomarkers, Am J Clin Nutr; ePub 2019 Mar 5; Hang, et al
Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al
Must Reads in Infectious Diseases
Invasive GBS Infections in Nonpregnant US Adults, JAMA Intern Med; ePub 2019 Feb 18; Francois Watkins, et al
Enterovirus in at-risk children associated with later celiac disease, Kahrs CR et al. BMJ. 2019 Feb 13. doi: 10.1136/bmj.l231
Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al